Search for: "PFIZER" Results 1561 - 1580 of 4,632
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 May 2015, 7:55 pm by Altman & Altman
Department of Justice Joins Whistleblowers in Medicare Fraud Cases Against Prominent Cardiologist, Boston Injury Lawyer Blog, January 13, 2015 Lipitor injury lawsuits against Pfizer blame the drug for diabetes, Boston Injury Lawyers Blog, January 9, 2015   [read post]
19 May 2015, 12:58 pm by DLT Team
Louis concluded last month the antidepressant Zoloft, manufactured by Pfizer Inc., did not cause birth defects in one case. [read post]
14 May 2015, 4:00 am by Paula Bremner
In Apotex v Pfizer Canada, 2014 FCA 250 [celecoxib NOC case], The Court of Appeal was focussed on interpreting the Promise in favour of Pfizer. [read post]
12 May 2015, 3:26 pm by James Galvin
., Inc. 902619386 UBS Yield Optimization Notes with Contingent Protection linked to General Electric Company 902619394 UBS Yield Optimization Notes with Contingent Protection linked to Exxon Mobil Corp. 902619493 UBS Yield Optimization Notes with Contingent Protection linked to Texas Instruments Inc 902619519 UBS Yield Optimization Notes with Contingent Protection linked to Amgen Inc. 902619527 UBS Yield Optimization Notes with Contingent Protection linked to Goldcorp Inc. 902619535 UBS Yield… [read post]
8 May 2015, 7:31 pm by Lawrence B. Ebert
Or pharmaceutical company Pfizer  AKAM 1.58% , which has an R&D budget of over $7 billion. [read post]
7 May 2015, 7:29 am by Robert Kraft
” Experts say that “the most reliable medical apps tend to result from collaborations among developers, physicians and experts in health law,” including HemMobile, an app from Pfizer that “helps hemophilia patients track their infusions. [read post]
29 Apr 2015, 8:09 am by Pete Strom
Jury Dismisses Zoloft Birth Defect Personal Injury Charges Against Pfizer After a one-week trial, the jury for the first Zoloft birth defects personal injury case ruled in favor of Pfizer,  concluding that the company did not fail to warn of dangers. [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
15 Apr 2015, 12:09 pm
Ct. 746 (2014), which we discussed here, the fact that Pfizer was registered to do business in West Virginia did not confer general jurisdiction over it on West Virginia’s courts. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
9 Apr 2015, 5:00 am
We’ve already discussed the peculiar decision in Watts v. [read post]
1 Apr 2015, 4:30 am
It was big news that there will be a six hour return of The X-Files, a show that dazzled us from 1993 to 2002. [read post]
26 Mar 2015, 7:07 am by Robert Kraft
The off-label marketing practices contributed to what the investors said were false and misleading statements about Pfizer’s financial performance, causing the company’s stock to trade at artificially inflated prices. [read post]
18 Mar 2015, 4:30 am by Kevin LaCroix
” To illustrate the later point, the report cites Pfizer’s January 2015 agreement to pay $400 million to settle the securities class action litigation pending against the company. [read post]